Amoxicillin for Enteral Nutrition Intolerance in Pediatric Intensive Care Unit
Status:
Not yet recruiting
Trial end date:
2024-05-10
Target enrollment:
Participant gender:
Summary
The goal of this randomized controlled study is to investigate the efficacy of enteral
amoxicillin for the treatment of children with feeding intolerance in pediatric intensive
care unit.
Children with feeding intolerance will be randomized into study and comparison groups. The
study group will receive amoxicillin 10 mg/kg by nasogastric tube 3 times daily 10 minutes
before bolus gastric feeding for 7 days. The comparison group will receive equal volume of
distilled water as a placebo.
The primary outcome will be the improvement of feeding intolerance on day 7 study timepoint.